You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Actavis Labs Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?

ACTAVIS LABS has one hundred and two approved drugs.

There are thirteen tentative approvals on ACTAVIS LABS drugs.

Summary for Actavis Labs
US Patents:0
Tradenames:88
Ingredients:81
NDAs:102

Drugs and US Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 079095-003 Mar 24, 2009 AB1 RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 077686-006 Mar 15, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 077198-003 May 13, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 203755-001 Aug 1, 2016 AB3 RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Ut Inc TESTOSTERONE testosterone GEL;TRANSDERMAL 204570-002 Jul 17, 2020 AB2 RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc LACOSAMIDE lacosamide TABLET;ORAL 204855-001 Jan 5, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.